Genomic testing can identify African American prostate cancer patients with high-risk disease

Report shows UPMC Hillman’s nearly $4B economic impact in Pennsylvania

A recent report showed that UPMC Hillman Cancer Center generated $3.98 billion in total economic impact in Pennsylvania through its clinical, research, and educational missions in 2023.

January 17, 2025

Vol.51 No.02

In Brief

Johns Hopkins, Howard University reform collaboration to advance health equity

A collaborative effort to eliminate cancer health disparities among African Americans and other underserved populations in the Washington, DC, area is being reignited at the Johns Hopkins Kimmel Cancer Center and the Howard University Cancer Center.

January 10, 2025

Vol.51 No.01

In Brief

UH Cancer Center and John A. Burns School of Medicine form initiative focused on health outcome disparities in Hawai‘i and the Pacific

The University of Hawai‘i Cancer Center and the John A. Burns School of Medicine are forming Ka ʻUmeke Lama, an initiative to transform cancer care in Hawaiʻi and the Pacific.

January 10, 2025

Vol.51 No.01

In Brief

ASC CAN: Congress missed a critical opportunity to prioritize cancer prevention and access to care

In December, Congress failed to advance a bipartisan year-end health care package that would have made a big difference in the fight against cancer, according to the American Cancer Society Cancer Action Network.

January 10, 2025

Vol.51 No.01

Clinical Roundup

A low omega-6, omega-3 rich diet + fish oil may slow prostate cancer growth, UCLA phase III trial finds

A new phase III trial led by UCLA Health Jonsson Comprehensive Cancer Center investigators found that a diet low in omega-6 and high in omega-3 fatty acids, combined with fish oil supplements, significantly reduced the growth rate of prostate cancer cells in men with early-stage disease.

January 10, 2025

Vol.51 No.01

Clinical Roundup

UCLA: Advanced imaging uncovers hidden metastases in high-risk prostate cancer cases

A new study led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center has found that many cases of high-risk nonmetastatic hormone-sensitive prostate cancer may be more advanced than previously thought.

January 10, 2025

Vol.51 No.01

Genomic testing can identify African American prostate cancer patients with high-risk disease

YOU MAY BE INTERESTED IN

Report shows UPMC Hillman’s nearly $4B economic impact in Pennsylvania

Johns Hopkins, Howard University reform collaboration to advance health equity

UH Cancer Center and John A. Burns School of Medicine form initiative focused on health outcome disparities in Hawai‘i and the Pacific

ASC CAN: Congress missed a critical opportunity to prioritize cancer prevention and access to care

A low omega-6, omega-3 rich diet + fish oil may slow prostate cancer growth, UCLA phase III trial finds

UCLA: Advanced imaging uncovers hidden metastases in high-risk prostate cancer cases

Renew today!

Subscriber content

Never miss an issue!

Login